Skip to end of metadata
Go to start of metadata
Labels
Page: A phase 2, randomized, 3-arm study of abiraterone acetate alone, AA plus degarelix, a GnRH antagonist, and degarelix alone for patients with prostate cancer with a rising PSA or a rising PSA and nodal disease following definitive radical prostatectomy  Page: A Randomized Controlled Trial of ProstAtak as Adjuvant to Up-Front Radiation Therapy for Localized Prostate Cancer Page: CALGB 70807 The Mens Eating and Living (MEAL) Study. A Randomized Trial of Diet to Alter Disease Progression in Prostate Cancer Patients on Active Surveillance Page: CUA - A Phase 2 multicenter prospective open label 2-dose level clinical safety and efficacy evaluation of injection of NX-1207 for the treatment of low risk, localized (T1c) Prostate Cancer. Page: CUA - A Phase 2 multi-center prospective open label 2-dose level clinical safety and efficacy evaluation of injection of NX-1207 for the treatment of low risk, localized (T1c) Prostate Cancer. Page: GWU - A Multicenter Phase 2, Randomized, Double-Blind, Efficacy and Safety Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer Who Have Failed Primary Androgen Deprivation Therapy Page: INOVA - A Phase III Trial of Short Term Androgen Deprivation With Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients With a Rising PSA After Radical Prostatectomy Page: INOVA - A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer Page: JHMI - A Neoadjuvant Immunologic Study of Androgen Deprivation Therapy Combined With a GM-CSF-secreting Allogeneic Prostate Cancer Vaccine and Low-dose Cyclophosphamide in Men With High-risk Localized Prostate Cancer Undergoing Radical Prostatectomy Page: JHMI - Multiparametric MRI for Assessing Radiotherapy Treatment Response of Prostate Cancer Page: NCI 09-C-0120 An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated Skin Page: NCI 11-c-0098 Evaluation of Ferumoxytol enhanced MRI for the detection of lymph node involvement in CaP Page: NCI 11-C-0158 MR Image Guided Focal Therapy in Prostate Cancer Page: NCI 13-c-0119 Evaluation of local response of CaP to irradiation using multiparametric MRI & MR guided biopsies Page: NCI 09-C-0120 An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated Skin Page: NCI - A Phase II Trial of Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer Page: new study Page: Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol and daily genistein (G-2535) versus placebo in men with early stage prostate cancer undergoing prostatectomy  Page: Phase II Study to Evaluate the Efficacy of Intensity Modulated Radiation Therapy with Hypofractionated Radiosurgical Boosts in the Treatment of Clinically Localized Prostate Cancer Page: Prospective Endoscopic Safety Evaluation of Late Rectal Mucosal Injury Following CyberKnife Radiosurgery for Clinically Localized Prostate Cancer Page: RTOG 0831 A Randomized, Double-blind, Placebo-controlled Phase III Trial to Evaluate the Effectiveness of a Phosphodiesterase 5 Inhibitor, Tadalafil, in Prevention of Erectile Dysfunction in Patients Treated With Radiotherapy for Prostate Cancer Page: Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients with High Risk localized Prostate Cancer Page: UMD - Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer. A Phase III Randomized Trial Page: UMD - A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy With or Without Short-Term Androgen Deprivation Therapy for Patients With Intermediate-Risk Prostate Cancer Page: UMD - A Phase III Trial of Short Term Androgen Deprivation With Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients With a Rising PSA After Radical Prostatectomy Page: UMD - A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy Page: UMD - Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy Versus Immediate Radical Prostatectomy in Patients With High-Risk, Clinically Localized Prostate Cancer Page: WHC - CALGB 70807 The Mens Eating and Living (MEAL) Study. A Randomized Trial of Diet to Alter Disease Progression in Prostate Cancer Patients on Active Surveillance Page: WRNMMC - A Multicenter Clinical Study of the Sonablate 500 (Sonablate) for the Treatment of Locally Recurrent Prostate Cancer With HIFU Page: WRNMMC - A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer Page: WRNMMC - A Randomized Controlled Trial of ProstAtak as Adjuvant to Up-front Radiation Therapy For Localized Prostate Cancer Page: WRNMMC - Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy Versus Immediate Radical Prostatectomy in Patients With High-Risk, Clinically Localized Prostate Cancer Page: WRNMMC - The Men's Eating and Living (MEAL) Study - A Randomized Trial of Diet to Alter Disease Progression in Prostate Cancer Patients on Active Surveillance